Clinical Trial

Bronchial Ablation for Treatment of Asthma (BATA) Trial

Study acronym: BATA
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 2, 2023 (before its estimated August 15, 2024 completion). Its status may not reflect the trial's current state.
Summary
To evaluate the safety and efficacy of a bronchial radiofrequency ablation system (SyMap Medical (Suzhou) Ltd) in a population of subjects with severe asthma who are still symptomatic despite being managed on high-dose Inhaled Corticosteroids (ICS) and Long-Acting β2-adrenergic Agonists (LABA).
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2018-12-04; most recent amendment 2023-07-31.
Status change: Recruiting → Active, Not Recruiting 2023-07-31
Status change: Not Yet Recruiting → Recruiting 2019-09-23
Trial Details
NCT Number NCT03765307
Lead Sponsor SyMap Medical (Suzhou), Ltd.
Collaborators: JieNuo Medical(Beijing)Co.,Ltd
Conditions Asthma
Enrollment 160 participants
Start Date 2019-06-18
Primary Completion 2024-08-15 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2023-08-02